Europe

View All
December 22, 2021 Off

UAB, Mereo good results in Phase 1b/2 Trial of Alvelestat for hospitalized patients with COVID-19

By Dino Mustafić

The University of Alabama at Birmingham (UAB) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced top-line data from a Phase 1b/2 clinical trial evaluating alvelestat, a novel, orally active...

USA

View All
January 19, 2022 Off

Pfizer’s Paxlovid reduced risk of hospitalization or death by nearly 90% compared to placebo

By Dino Mustafić

Pfizer said Wednesday that the results from multiple studies showed the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets), is...

My Pharmaceutical

View All
April 22, 2021 Off

Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19

By Author

A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy...

April 13, 2021 Off

Drug testing approach uncovers effective combination for treating small cell lung cancer

By Author

Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small...

March 25, 2021 Off

Scientists find evidence that novel coronavirus infects the mouth’s cells

By Author

An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....